Hongyu Yang
Shenyang Pharmaceutical University(CN)Hebei Medical University(CN)Ministry of Education of the People's Republic of China(CN)Zunyi Medical University(CN)Jilin University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Kunming Medical University(CN)Civil Aviation University of China(CN)Chengdu Sport University(CN)Second Hospital of Hebei Medical University(CN)First Hospital of Jilin University(CN)Peking University First Hospital(CN)First Affiliated Hospital Zhejiang University(CN)Zhejiang University(CN)University of South China(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases, Aortic aneurysm repair treatments, Salivary Gland Tumors Diagnosis and Treatment, Reproductive tract infections research
Most-Cited Works
- → Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease(2017)298 cited
- → Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer’s Disease Drug Discovery(2018)113 cited
- → Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor(2020)104 cited
- → Flexible Grid Connection Technique of Voltage-Source Inverter Under Unbalanced Grid Conditions Based on Direct Power Control(2015)84 cited
- → Discovery of new acetylcholinesterase and butyrylcholinesterase inhibitors through structure-based virtual screening(2017)66 cited
- → Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease(2018)63 cited